Further LNP safety validation | ABUS Message Board Posts

Arbutus Biopharma

  ABUS website

ABUS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34283 of 34731  at  4/25/2018 3:47:55 PM  by

egomaniakos


Further LNP safety validation


This is just for the benefit of jetmanbash who constantly conflated the risks of 24 hour steroid prophylaxis with chronic steroid use. Additional Apollo data for Patisaran, with post hoc analyses suggesting improved survival also demonstrated:
 
https://www.investorvillage.com/smbd.asp?mb=569&mn=34097&pt=msg&mid=18230127 
 
 
The IONS hope is that Patisaran won't have 80% market share but more like 50-50. They are deluded. I would be surprised if they get 20% market share, IF, they get approved. Hard to approve a drug that is less safe and less efficacious at the same time as another drug that is bettwer on both counts.
 
ego


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 5     Views: 401
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...